Joseph Wright - Feb 28, 2023 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Role
CHIEF COMMERCIAL OFFICER
Signature
/s/ Brian G. Lloyd, Attorney-in-Fact
Stock symbol
MMSI
Transactions as of
Feb 28, 2023
Transactions value $
-$225,362
Form type
4
Date filed
3/2/2023, 07:20 PM
Previous filing
Nov 9, 2022
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MMSI Common Stock, No Par Value Award $0 +10.2K +43.45% $0.00 33.6K Feb 28, 2023 Direct F1
transaction MMSI Common Stock, No Par Value Tax liability -$225K -3.19K -9.5% $70.58 30.4K Feb 28, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MMSI Non-qualified stock options (right to buy) Award $0 +13.6K $0.00 13.6K Feb 28, 2023 Common Stock 13.6K $70.58 Direct F3
holding MMSI Non-qualified stock options (right to buy) 9.68K Feb 28, 2023 Common Stock 9.68K $56.25 Direct F4
holding MMSI Non-qualified stock options (right to buy) 25K Feb 28, 2023 Common Stock 25K $28.20 Direct F5
holding MMSI Non-qualified stock options (right to buy) 25K Feb 28, 2023 Common Stock 25K $44.80 Direct F6
holding MMSI Non-qualified stock options (right to buy) 30K Feb 28, 2023 Common Stock 30K $55.73 Direct F7
holding MMSI Non-qualified stock options (right to buy) 16.7K Feb 28, 2023 Common Stock 16.7K $37.71 Direct F8
holding MMSI Non-qualified stock options (right to buy) 8.09K Feb 28, 2023 Common Stock 8.09K $65.03 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired upon a determination of the Company's Compensation and Talent Development Committee that certain conditions had been met for the issuance of such shares pursuant to performance stock units that were granted on 02.26.2020 and 03.19.2021.
F2 These shares were not sold in an open-market transaction.
F3 Becomes exercisable in equal annual installments of 25% commencing on 02/28/2024.
F4 Becomes exercisable in equal annual installments of 25% commencing on 03/19/2022.
F5 Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
F6 Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.
F7 Becomes exercisable in equal annual installments of 20% commencing on 03/01/2020.
F8 Becomes exercisable in equal annual installments of 25% commencing on 02/26/2021.
F9 Becomes exercisable in equal annual installments of 25% commencing on 02/28/2023.